hero phase 3 trial: relugolix vs. leuprolide acetate for advanced prostate cancer
Published 4 years ago • 1.6K plays • Length 8:51Download video MP4
Download video MP3
Similar videos
-
11:09
hero phase 3 trial: relugolix vs. leuprolide acetate for advanced prostate cancer - interview
-
4:43
hero phase iii trial in advanced prostate cancer
-
4:35
hero: relugolix versus leuprolide acetate for advanced prostate cancer
-
5:29
relugolix and concomitant treatment for advanced prostate cancer
-
1:50
dr. shore on the safety profiles of relugolix and leuprolide acetate in prostate cancer
-
21:55
the hero study and the approval of relugolix
-
4:53
asco: relugolix vs leuprolide for advanced prostate cancer
-
3:33
listen: phase 3 hero trial
-
4:59
hero: relugolix as an oral androgen-deprivation therapy in prostate cancer
-
10:51
advanced prostate cancer clinical trials update 2022
-
2:16
fda approves relugolix for advanced prostate cancer
-
1:42
dr. shore on the rationale for the phase 3 hero trial in advanced prostate cancer
-
19:50
new standards of care for advanced prostate cancer
-
28:33
top talk (ep 2) - explore the prog & exp of relugolix in the treatment of prostate cancer.
-
5:08
cardiovascular & metabolic risk profiles of hormonal agents for managing advanced prostate cancer
-
27:50
new concepts in adt
-
12:24
gu asco symposium 2022 summary
-
15:33
standard treatment for advanced prostate cancer
-
17:44
new approaches to metastatic hormone sensitive prostate cancer